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Serogroup CSummary Objectives: Neisseria meningitidis is a leading cause of meningitis and septicae-
mia. The hyperinvasive ST-11 clonal complex (cc11) caused serogroup C (MenC) outbreaks in
the US military in the 1960s and UK universities in the 1990s, a global Hajj-associated serogroup
W (MenW) outbreak in 2000e2001, and subsequent MenW epidemics in sub-Saharan Africa.
More recently, endemic MenW disease has expanded in South Africa, South America and the
UK, and MenC cases have been reported among European and North American men who have
sex with men (MSM). Routine typing schemes poorly resolve cc11 so we established the popu-
lation structure at genomic resolution.
Methods: Representatives of these episodes and other geo-temporally diverse cc11 meningo-
cocci (n Z 750) were compared across 1546 core genes and visualised on phylogenetic net-
works.
Results: MenW isolates were confined to a distal portion of one of two main lineages with MenB
and MenC isolates interspersed elsewhere. An expanding South American/UK MenW strain was
distinct from the ‘Hajj outbreak’ strain and a closely related endemic South African strain.
Recent MenC isolates from MSM in France and the UK were closely related but distinct.
Conclusions: High resolution ‘genomic’ multilocus sequence typing is necessary to resolve and
monitor the spread of diverse cc11 lineages globally.
Crown Copyright ª 2015 Published by Elsevier Ltd on behalf of The British Infection
Associat ion. This is an open access art icle under the CC BY l icense (http://
creativecommons.org/licenses/by/4.0/).Introduction
The Gram-negative bacterium Neisseria meningitidis, the
meningococcus, is principally a commensal that colonises
the nasopharynx of approximately 10% of humans. It is
also a leading cause of meningitis and septicaemia, being
associated with sporadic cases, outbreaks and epidemics
throughout the world.1 The principal meningococcal viru-
lence factor is the polysaccharide capsule which also defines
the serogroup. Serogroups A, B, C, W, X and Y are respon-
sible for most disease and vaccines are currently available
against serogroups A, C, W and Y.1,2 Bexsero, a recently
licensed vaccine against serogroup B organisms, targets sub-
capsular antigens2 and was developed in response to safety
and efficacy concerns surrounding the B polysaccharide.
Reference laboratories conventionally identify serogroups
and also type/subtype meningococci on the basis of outer
membrane proteins (OMPs). Meningococcal population
structure has been studied with multilocus sequence typing
(MLST) which classifies meningococci into clonal complexes
(ccs). Most invasive isolates belong to a limited number of
ccs, which correspond to the hyperinvasive lineages first
identified by multilocus enzyme electrophoresis (MLEE).3
Meningococci belonging to the ST-11 clonal complex
(cc11; also known as the ET-37 complex and lineage 11)
are hyperinvasive and may express serogroups C
(MenC:cc11) or W (MenW:cc11) and, less frequently, B
(MenB:cc11) or Y. They are associated with high rates of
morbidity and mortality4 and have a propensity to cause
outbreaks and epidemics. For example: cc11 meningococci
were responsible for serogroup B and C outbreaks in the US
military in the 1960s, leading to the implementation of the
first generation of meningococcal polysaccharide vaccines.5
Epidemics caused by MenC:cc11 in North America, Europe
and Australia in the 1990s/2000s, prompted the first use
of serogroup C glycoconjugate vaccines6 and in 2000 a
Hajj-associated outbreak of MenW:cc11 disease swept the
globe, persisting for several years.7 Since 2001, MenW:cc11has caused epidemics in the meningitis belt of Sub-Saharan
Africa.8 North America and Europe have recently experi-
enced several high-profile cases and outbreaks of
MenC:cc11 disease among men who have sex with men
(MSM), the first being identified in Toronto in 2001.9 From
2003, endemic MenW:cc11 disease increased in South Af-
rica, Brazil and, subsequently, several other South Amer-
ican countries where case fatality rates reached 28%.10,11
England and Wales have also seen a year-on-year increase
in endemic MenW:cc11 disease since 2009.12
Beyond the serogroup, currently used typing schemes
offer limited resolution among cc11 meningococci. PorB
OMP serotypes 2a or NT (non-typable using antisera avail-
able from the National Institute for Biological Standards and
Control, Potters Bar, UK) are broadly distributed within the
cc, whilst almost all MenW:cc11 organisms and a large
proportion of MenC:cc11 organisms express the PorA OMP
subtype P1.5,2. MLEE was instrumental in identifying the
‘ET-15’ subpopulation responsible for the elevated
MenC:cc11 disease of the 1990s/2000s, as well as among
MSM cases.9 This labour intensive and poorly portable
scheme was superseded in late 1998 by MLST13; however,
the majority of cc11 disease isolates exhibit a single
sequence type (ST-11). PorA also poorly resolves these
meningococci as, although subtypes P1.5-1,10-8 and P1.5-
1,10-4 are the most common, a large proportion exhibit
the widespread P1.5,2 subtype.14 Consequently, research
groups and reference laboratories have targeted individual
ET-15 markers such as the genomic presence of the insertion
sequence IS1301 or the fumerase (fumC ) gene mutation
responsible for the characteristic electropherotype.15,16 As
none of the typing markers employed to date are satisfac-
tory, there is uncertainty as to the relatedness of current
and historical cases and the provenance of emerging cc11
strains. Isolates typed as MenW:cc11, for example, are often
described as ‘the Hajj strain’ with no direct evidence that
they are closely related.17
Whole genome sequencing (WGS) of meningococcal ge-
nomes is currently the most cost effective method for
546 J. Lucidarme et al.meningococcal typing for surveillance, especially with the
advent of protein-based serogroup B vaccines that include
antigens not historically used for typing.2 The Meningitis
Research Foundation Meningococcus Genome Library (MGL)
is an exemplar of this concept, containing genomes for all En-
glish and Welsh and Northern Irish invasive isolates received
by the Public Health England Meningococcal Reference Unit
(MRU) from July 2010 to June 2013 (inclusive). These high-
resolution data facilitate surveillance and the identification
of outbreaks. The power of the MGL is enhanced by its capac-
ity to compare current data to historical and international
cases within the broader PubMLST Neisseria database e an
open access repository of Neisserial isolate data including
provenance, pheno/genotyping data and, increasingly, whole
genome sequences, submitted by researchers and reference
laboratories around the world (http://pubmlst.org/
neisseria/). The elevated levels of disease caused by cc11
and the historical significance of these hyperinvasive menin-
gococci make them a priority for such an analysis. Here we
investigated an extensive panel of cc11 isolates, including
representatives of high-profile disease episodes from the pre-
sent and recent past, to address these issues.
Methods
Isolates and genomes
All genomes are available open access in the PubMLST Neis-
seria database (accessed 29 October 2014). Unique PubMLST
IDs and typing data are listed in Supplementary Table 1. Ge-
nomes of 448 of the isolates were sequenced, assembled
and annotated as part of the present study, as described
previously.18 The isolates covered in the study comprised a
mixture of MGL isolates, isolates from noteworthy episodes
of cc11 disease (mainly sequenced for the purpose of the
study) and other available cc11 genomes on the PubMLST
Neisseria database (Supplementary methods).
Briefly, the study included genomes for 750 cc11 isolates
comprising 246 serogroup C isolates, 470 serogroup W
isolates and 34 serogroup B isolates. These included 663
invasive disease isolates, 40 upper respiratory tract car-
riage isolates and 47 isolates from unspecified or unknown
sites. There were 522 isolates from the UK and 228
representing 24 other countries across five continents and
several decades (Supplementary Table 2) including
MenW:cc11 isolates from English, Welsh and French Hajj
pilgrims (2000e2004), North Africa (1996e2004), South Af-
rica (2003e2013), Brazil (2008e2011), Argentina
(2008e2012) and England and Wales (2009e2014); ET-15
and non-ET-15 MenB:cc11 and MenC:cc11 isolates from Eu-
rope and North America from the mid 1990s to the present;
and MenC:cc11 isolates from MSM cases in Toronto (2001),19
England (2011e2013) and France (2013).20
Two diverse non-cc11 isolates (PubMLST IDs 29645 (cc8)
and 27778 (cc41/44)) were included in order to identify a
putative origin for the cc11 lineage.
Phylogenetic analyses
Genomes were compared using the PubMLST Genome
Comparator tool,21 which employs a ‘gene by gene’approach comparing arbitrary, sequentially assigned, pre-
indexed allele identifiers at each locus.18 A set of 1546 in-
dexed core genome (cg) loci were used for comparisons
as described previously.12 SplitsTree4 (version 4.12.8) was
used to visualise the resulting distance matrices as
Neighbour-net networks.18,22Role of the funding sources
The funding sources for the study had no role in study
design, data collection, data analysis, data interpretation,
or writing of the report. The corresponding author had full
access to all the data in the study and had final re-
sponsibility for the decision to submit for publication.Results
A comparison of all of the genomes demonstrated a
relatively close relationship between the cc11 and cc8
genomes versus that of the cc41/44 isolate (Fig. 1a). The
cc11 genomes formed a single main lineage comprising
two sublineages, lineage 11.1 and lineage 11.2, bifurcating
from the non-cc11 genomes. Both sublineages gave rise to
several clusters, each representing periods of putative
clonal expansion. The serogroup W isolates were confined
to several relatively distal clusters within lineage 11.1
whilst the serogroup B and C isolates were confined to
the remaining lineage 11.1 clusters and all of lineage 11.2
(Fig. 1b).Lineage 11.2 e the ‘ET-15 lineage’
Lineage 11.2 comprised solely serogroup B and C isolates.
Isolates from several European countries, South Africa and
Canada were well distributed within the sublineage
(Fig. 2a). To our knowledge, all of the known ET-15 isolates
(as determined by MLEE) were found in lineage 11.2, as
were all isolates possessing the characteristic ET-15 fumC
polymorphism and the majority of isolates with the cc11/
ET-15 marker, IS1301. Only three isolates (those nearest
to the origin of the sublineage) lacked both of the latter
ET-15 markers. A further isolate within the mainly PorA
P1.5,2 cluster (PubMLST ID 1178) lacked the fumC polymor-
phism. The temporal distribution of the isolates largely re-
flected the longitudinal expansion of the population over
time with the earliest isolates relatively close to the origin
of the sublineage whilst the distal portion was dominated
by the most recent isolates (Fig. 2b). The serogroup B and
C isolates were broadly interspersed throughout the subli-
neage (Fig. 2c). The Canadian MSM outbreak isolates were
almost identical to one-another whilst the recent English
and French MSM isolates were relatively distinct from one
another and were interspersed among sporadic cases in
the wider community (Fig. 2c). Notably, however, the
French and English MSM isolates shared a relatively recent
common ancestor within the most distal cluster. Isolates
with PorA P1.5,2 dominated the clusters closest to the
origin of the sublineage giving way to P1.5-1,10-8 in the




























Figure 1 Population structure and serogroup distribution
among geographically and temporally diverse meningococcal
cc11 isolates versus non-cc11 isolates. (a) Neighbour-net phylo-
genetic network based on a comparison of 1546 core genome
loci among geographically and temporally diverse cc11 isolates
(nZ 750) and two non-cc11 isolates (cc8 and cc41/44, respec-
tively). The cc11 isolates bifurcated into two main sublineages
(lineages 11.1 and 11.2), each containing several clusters of
isolates. Panel (b) illustrates the serogroup distribution
whereby serogroups B (MenB) and C (MenC) were present in
both sublineages while serogroup W (MenW) isolates were
confined to the intermediate and distal regions of lineage
11.1. The scale bar indicates the number of differences among
the 1546 loci compared.
The ST-11 clonal complex 547Lineage 11.1
Lineage 11.1 (non-ET-15) serogroup B and C isolates
The remaining serogroup B and C isolates, including most of
the isolates from pre-1990 (17/21), were confined to
several closely related clusters and singletons located
near to the origin of lineage 11.1 (Fig. 1a and b,
Supplementary Table 1 ‘lineage 11.1 proximal region’). In
the current collection, most of these serogroup C isolates
were from the UK (n Z 49/65; 1970e2014), but they also
included isolates from Ireland (n Z 5, 2001e2011), Malta
(n Z 2, 2006e2013), Spain (n Z 1, 1985), Italy (n Z 1,
1984), Israel (n Z 1, 1988), Ghana (n Z 1, 1984), Mali
(n Z 1, 1989), Brazil (n Z 1, 1976), Canada (n Z 2,2008e2009), and the USA (n Z 1, 1983). The majority of
these (47/65) possessed PorA P1.5,2, with P1.5,2-1
(nZ 12) predominating in a single cluster that included iso-
lates from the UK (nZ 8, 1985e2005), Malta (nZ 1, 2006),
Spain (nZ 1, 1985), Israel (nZ 1, 1988) and Ghana (nZ 1,
1984). Most of the isolates from 2007 onwards (19/21) were
found in a single cluster comprising isolates from the UK
(n Z 18, 1998e2014), Ireland (n Z 1, 2011), Malta
(n Z 1, 2013), and Canada (n Z 2, 2008e2009). Four se-
rogroup B isolates in this region were interspersed among
the serogroup C isolates and were from England and Wales
(2001 and 2012), Norway (1969), and the USA (1964).
Lineage 11.1 serogroup W isolates
The serogroup W isolates were exclusively located in the
relatively intermediate and distal regions of lineage 11.1,
where they were segregated from the serogroup B and C
isolates (Fig. 1a and b). In the intermediate region were
two clusters of South African isolates (n Z 15,
2003e2013; and nZ 9, 2003e2011), a cluster of UK isolates
(n Z 6, 1975e1990), and several unclustered UK isolates
(n Z 8, 1996e2007). The latter South African cluster
comprised all PorA P1.5-1,2 isolates whilst the majority of
all of the remaining serogroup W isolates (452/471) were
P1.5,2.
The distal region of lineage 11.1 bifurcated into two
main sublineages and a small intermediate cluster, the
latter comprising isolates from the UK (nZ 8, 1996e2000),
South Africa (n Z 8, 20032004), Algeria (n Z 1, 1999) and
Chad (nZ 1, 1996) (Fig. 3). Within one of the two main sub-
lineages was a tight cluster including the two French Hajj
pilgrim isolates and almost all (118/120) of the English
and Welsh MenW:cc11 isolates from the Hajj outbreak
period (2000e2004), including those of 14 pilgrims and 41
pilgrim contacts. These were accompanied by several North
African isolates from the same period, and more recent iso-
lates from Turkey (nZ 3, 2005/6) and France (nZ 1, 2014)
(Fig. 3, ‘Anglo-French Hajj strain’). Slightly more distal
within the same sublineage was the main South African
isolate cluster comprising 79/112 South African isolates
(2003e2013) and two English isolates (2007 and 2012)
(Fig. 3, ‘endemic South African strain’). Towards the origin
of this sublineage were two further clusters, respectively
comprising isolates from Burkina Faso (n Z 3,
2001e2004), Niger (n Z 10, 2001e2013) and the UK
(n Z 1, 1998), and Burkina Faso (n Z 4, 2001e2004),
Cameroon (n Z 4, 2000e2001) and the UK (n Z 1, 2001)
(Fig. 3, ‘Burkina Faso/North African isolates’).
The other main sublineage in the distal region of lineage
11.1 contained a large cluster comprising invasive isolates
from England and Wales (n Z 117, 2009e2013), Ireland
(n Z 3, 2013) and France (n Z 1, 2014), as well as 29
MenW:cc11 carriage isolates from five of the six universities
partaking in a recent UK carriage study.23 Towards the
origin of this sublineage were two further clusters, respec-
tively comprising isolates from Argentina (n Z 5,
2008e2012) and England and Wales (n Z 2, 2010e2014);
and Brazil (nZ 6, 2008e2011). A further isolate from Brazil
was located between the latter two clusters (Fig. 3, South
American/UK strain).
Ten serogroup W isolates possessed IS1301 e four ‘South
American/UK strain’, five ‘endemic South African strain’ (of
Figure 2 Geo-temporal, serogroup and serotype distributions of meningococcal lineage 11.2 isolates and the distribution of inva-
sive isolates from British and French men who have sex with men. The inset in section (a) indicates the region of cc11 represented
by lineage 11.2. The corresponding isolates were compared, along with 71 diverse representatives of lineage 11.1 (Supplementary
Table 1 e highlighted yellow), in terms of 1546 core genome loci to generate the Neighbour-net phylogenetic network in sections
(a) to (d). The large arrow represents the lineage 11.1 isolates. (a) The relatively populous UK isolates (no marker) were broadly
interspersed among isolates from countries representing several continents. (b) The diversification of the sublineage was reflected
in the temporal distribution of the isolates, with more recent isolates often observed at the more distal regions of the lineage.
Section (c) highlights the distribution of (i) serogroup B isolates which were highly interspersed among the serogroup C isolates
(no markers), (ii) MenC:cc11 genomes from the Toronto MSM outbreak (Canada MSM), and (iii) the relatively diverse recent UK
and French MSM cases that were interspersed with cases from the wider community. Section (d) depicts the distribution of PorA
subtypes in which the isolates in the relatively proximal clusters (versus the origin of the sublineage) were mainly P1.5,2 or
P1.5-1,10-4, whilst isolates within more distal clusters were mainly P1.5-1,10-8. The scale bar in section (a) indicates the number
of differences among the 1546 loci compared.
548 J. Lucidarme et al.which one was isolated in England/Wales), and one ‘Anglo-
French Hajj strain’ (isolated in Turkey 2006).Discussion
For at least fifty years, isolates belonging to meningococcal
cc11 have been responsible for outbreaks and epidemics of
invasive meningococcal disease. The most recent concern is
a possible international outbreak of MenC:cc11 disease
among MSM and the demonstrated expansion of MenW:cc11
disease in England and Wales, South Africa and South
America where associated case fatality rates have been
particularly high. The poor discriminatory value of routine
typing schemes against cc11 isolates has led to uncertainty
as to the relatedness of current and historical cases and the
provenance of emerging strains. In the present study, WGS
data from several countries over several decades werecompared to generate a high resolution framework for cc11
epidemiology.
The present analysis confirmed the previously described
close relationship between cc11 and cc8 meningococci.24
The cc11 isolates comprised two major sublineages (lineage
11.1 and lineage 11.2) diverging from the non-cc11 isolates,
as has previously been shown with fewer isolates.18,25 The
serogroup B and C isolates were present in both sublineages
with the confirmed ET-15 isolates and all isolates possessing
the characteristic ET-15 fumC polymorphism confined to
lineage 11.2. An isolate located deep within lineage 11.2
lacked the fumCmutation, probably through recombination
which is common in meningococci. The majority of isolates
possessing IS1301 were also found in this sublineage, though
a diverse set of lineage 11.1 isolates also appear to have ac-
quired the insertion sequence following the divergence of
the two sublineages. Three further lineage 11.2 isolates
lacking these ET-15 markers were located close to the
Figure 3 Geo-temporal distribution of isolates within distal sublineages of meningococcal lineage 11.1. The inset (top-right) de-
picts a cgMLST (1546 loci) Neighbour-net phylogenetic network of all 750 geo-temporally diverse cc11 isolates and two non-cc11
isolates (cc8 and cc41/44) highlighting the distal region of lineage 11.1 that bifurcates into two sublineages. Isolates corresponding
to this region underwent a separate cgMLST (1546 loci) comparison to generate the Neighbour-net network in the main figure. Both
sublineages contained several clusters, each relating to a noteworthy episode of serogroup W disease. One lineage included strains
relating to the Hajj outbreak of 2000 onwards (Anglo-French Hajj strain), the expansion of endemic MenW:cc11 disease in South
Africa from 2003 (endemic South African Strain) and a period of MenW:cc11 epidemics in sub-Saharan Africa (Burkina Faso/North
African Strains). The other sublineage contained clusters relating to expanding endemic MenW:cc11 disease in South America and
the UK (the South American/UK strain). Dots relate to individual cases. The scale bar indicates the number of loci differing among
the 1546 compared.
The ST-11 clonal complex 549origin of lineage 11.2 indicating that the markers became
‘fixed’ sometime after the initial divergence of lineages
11.1 and 11.2.
The results were consistent with serogroup B and C
capsular switching events26 occurring on multiple occa-
sions, rather than a small number of rare events giving
rise to several persistent serogroup B strains. The relatively
large distances observed among the English/Welsh and
French MSM isolates, and the fact that they were inter-
spersed among sporadic community cases, suggest that
these did not constitute an outbreak comprising a close
transmission network, as was observed among the epidemi-
ologically linked Toronto cases for which the isolates were
practically identical to one-another.19 The distribution of
P1.5-1,10-8 among our panel suggests that other recent
MSM isolates with this PorA subtype would also fall into
these closely related clusters. Inclusion of such isolates in
future analyses will establish the extent and distributionof outbreaks. It remains possible that isolates located in
more distal clusters of lineage 11.2 have a genuine associa-
tion with disease in this community, perhaps due to a pro-
pensity to colonise a genitourinary niche, although this
remains to be established.9
All of the serogroup W isolates were located in lineage
11.1 and were distinct from the serogroup B and C isolates.
The lineage 11.1 cluster that included invasive isolates
from Hajj pilgrims (the ‘Anglo-French Hajj strain’) can be
considered a Hajj-associated outbreak strain. Analysis of
genomes of Hajj outbreak isolates from other countries
including Saudi Arabia will confirm whether this was
responsible for the wider outbreak or there was a concur-
rent outbreak due to a distinct strain. It is possible that the
North African isolates belonging to this cluster also formed
part of the Hajj outbreak, thereby supporting a ‘single
origin’ outbreak. Conversely, they may represent an
endemic African strain from which the outbreak arose: all
550 J. Lucidarme et al.of these isolates were listed as sporadic cases except one
that was listed as epidemic. The predominance of North
African isolates in two closely related, but relatively less
distal, clusters adds support to this contention. These
included four isolates each from Burkina Faso between
2001 and 2004 (each listed as ‘epidemic’). Thus these and
the Anglo-French Hajj strain appear to have diverged from
a single, relatively recent ancestor. This also highlights the
presence of at least two MenW:cc11 strains in Burkina Faso
at the time of the large MenW:cc11 epidemics,8 neither of
which corresponded to a confirmed Hajj strain. The related
UK strain from 2001 was confirmed to have no epidemiolog-
ical link to the Hajj outbreak.
The South African MenW:cc11 isolates were diverse,
being located in several clusters in the distal and interme-
diate regions of lineage 11.1. The predominant cluster,
however, was very closely related to, and apparently
divergent from, the Anglo-French Hajj strain. Given that
the increase in endemic MenW:cc11 disease in South Africa
began in 200310 (shortly after the onset of the Hajj
outbreak in 2000), it is likely that this strain was introduced
during or shortly after the outbreak, at which point it
became endemic for several years. The Anglo-French Hajj
strain was also detected in more recent isolates from
France (2014) and Turkey (2005/6) where it has been spec-
ulated to persist as an endemic strain.27
Importantly, this WGS analysis demonstrates that the
MenW:cc11 strain which is currently endemic in Brazil,
Argentina and England and Wales, the ‘South American/UK
strain’, is distinct from the Hajj outbreak strain. It is also
epidemiologically distinct with a tendency to persist, as
compared with the Anglo-French Hajj and South African
strains for which elevated disease rates subsided relatively
quickly.7 Despite the comprehensiveness of the panel of
recent English and Welsh MenW:cc11 case isolates, the
South American/UK strain was not observed in these two
countries prior to 2008. It is interesting that the positions
of the Brazilian, Argentinean and English/Welsh clusters,
relative to the origin of the sublineage, reflected the time-
line in which each country began to experience increased
disease. Also interesting is the fact that isolates from two
English cases (2010 and 2014) formed a cluster with the Ar-
gentinean isolates. These observations are consistent with
the suggestion that this strain has spread recently from
South America and become endemic in England and Wales.
Furthermore, one of the Brazilian isolates occupied an in-
termediate node part way between the Brazilian and Ar-
gentinean clusters perhaps indicating that similar
processes are leading to endemic disease elsewhere. Infor-
mation from Chilean isolates would provide useful addi-
tional information, as this is the most recent South
American country to report the expansion of MenW:cc11
disease. One of the advantages of the PubMLST Neisseria
database is that comparable data are available to refer-
ence laboratories worldwide and will facilitate the moni-
toring of global epidemiology.
Owing to the high case fatality rates and persistence of
MenW:cc11 disease in South America, the relatedness of
the currently expanding UK strain is of concern. The
English/Welsh strain has already exhibited similar behav-
iour by expanding first among the elderly and subsequently
all age groups. Results of the current study show that thestrain was being carried in at least five of the six institutions
partaking in the UK carriage study from 2010 to 2012.23 In
June 2013 the UK introduced a serogroup C booster among
adolescents to maintain herd protection in cohorts vacci-
nated in infancy/early childhood since the initial introduc-
tion of the vaccine.28 Concerns over the accelerated
increase in endemic serogroup W disease caused by a
particularly virulent strain have prompted plans to offer
quadrivalent serogroup A, C, W and Y vaccine to teenagers
later in 2015. The universal presence of full length nadA
genes within this strain indicates that a recently licensed
protein-based serogroup B vaccine Bexsero29 may afford
protection when it is introduced for use in infants in
September 201530 and this is supported by early hSBA
studies using pooled pre- and post-vaccination infant sera
(unpublished data).
In summary, large-scale genomic comparisons of a broad
panel of geographically and temporally varied isolates
revealed a genetically diverse global cc11 population.
There are numerous strains currently circulating in
different countries, some of which exhibit different epide-
miological properties. The comprehensive UK and South
African panels and selected isolates representing various
episodes such as the Hajj outbreak and South American
MenW:cc11 isolates are likely to be highly representative of
their respective countries/cc11 disease episodes. The
numerous miscellaneous isolates, although not necessarily
representative of their respective countries, provide a
diverse geo-temporal backdrop with which to view these
episodes whilst maintaining a population structure domi-
nated by two main sublineages. As further isolates/ge-
nomes are added from different countries and times, the
overall picture will develop further. The analyses described
here are readily reproducible using pubMLST.org infrastruc-
ture and will facilitate ongoing high-resolution global sur-
veillance as more countries embrace routine WGS
analysis. It will also better inform intervention strategies
on national and global levels.Declaration of interests
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